NanoEcho AB (publ) (NANECH) fair value: what the stock is really worth
We calculate from audited financials what NanoEcho AB (publ) is really worth. The fair value tells you whether the price is too high or too low, the quality score (0 to 100) how solid the business behind it is. 26 models, 37 quality factors, updated daily.
Valuation from Jul 17, 2026. With the latest figures (losses, negative cash flow), a fair value can no longer be calculated.
Watch NanoEcho AB (publ) for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
NanoEcho AB (publ) engages in developing a new diagnostic method to determine the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is headquartered in Lund, Sweden.
Stock analysis
NanoEcho AB (publ) (NANECH) currently trades at kr 0.0238, while our model-based Fair Value estimate is kr 0.0263, implying the stock looks roughly 9.5% undervalued today.
Show more
Valuation
How firm this estimate is: it rests on 1 models at a data quality of 91/100, which puts the evidence level at low.
Scenario range: kr 0.0263 (bear) to kr 0.0295 (bull), the price of kr 0.0238 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 19/100 (below-average quality), in the Healthcare sector.
Weak Growth: Revenue growth is weak, negative or inconsistent.
NanoEcho AB (publ) reported revenue of 488K SEK in FY2025 versus 0 SEK in FY2022. Reported net income was −15.7M SEK in FY2025.
Key figures
Market cap 16.2M SEK (≈ $1.6M) · P/S ratio 33.3 · EPS (TTM) kr −0.0500 · Return on equity −73.9% · Return on assets (EBIT) −78.4% · Operating margin −3,199% · Revenue (TTM) 487K SEK · Revenue growth (YoY) −82.7%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 43 out of 100 (low confidence).
What moves the price
The share trades about 79% below its 52-week high and at its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −5% fair-value upside, at 11%, NANECH screens cheaper than that median.
Fair Value models
Bear kr 0.0263Fair Value kr 0.0263Bull kr 0.0295
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.0/100
Revenue growth is weak, negative or inconsistent.
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Biotechnology · 654 stocks
Beats the industry median on 2/5 measures
A mixed picture versus its industry peers.
Valuation
Quality Score23 · Bottom 25%
Fair Value upside+11% · Top 25%
Profitability
Return on assets−39% · Bottom 25%
Growth and dividend
Revenue growth−83% · Bottom 25%
Valuation Multiplesvs Biotechnology median · lower = cheaper
P/B0.11× · book value is mostly goodwill ⓘGoodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "NanoEcho AB (publ) Fair Value". https://www.fairvalue-calculator.com/stock/NANECH
Frequently asked questions
Is NanoEcho AB (publ) (NANECH) overvalued or undervalued?
As of Jul 17, 2026, our model estimates a fair value of kr 0.0263 versus a price of kr 0.0238, about +11% upside (undervalued).
What is the fair value of NANECH?
Our model-based fair value for NanoEcho AB (publ) is kr 0.0263 (as of Jul 17, 2026), built from audited fundamentals. The current price: kr 0.0238.
What is the quality score of NANECH?
NanoEcho AB (publ) has a Quality Score of 19/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for NanoEcho AB (publ) (NANECH)?
Our model-based price target is the fair value of kr 0.0263 (as of Jul 17, 2026) from 1 valuation models. Cautious scenario kr 0.0263, optimistic scenario kr 0.0295. It is a calculation from audited fundamentals, not an analyst target.
What is the NanoEcho AB (publ) stock forecast for 2026?
Our models put fair value at kr 0.0263, about +11% upside versus a price of kr 0.0238 (undervalued). Cautious scenario kr 0.0263, optimistic scenario kr 0.0295. The calculation is refreshed regularly with new filings.
What is the revenue of NanoEcho AB (publ) (NANECH)?
NanoEcho AB (publ) reported trailing-twelve-month revenue of about 487K SEK (latest available figure, as of Jul 17, 2026).
What is the intrinsic value of NanoEcho AB (publ) (NANECH)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For NanoEcho AB (publ) it is kr 0.0263 per share (as of Jul 17, 2026), against a price of kr 0.0238. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is NanoEcho AB (publ) stock overvalued or undervalued in 2026?
As of Jul 17, 2026, NANECH trades below its calculated fair value: price kr 0.0238, fair value kr 0.0263, a gap of about +11% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of NANECH?
No. The price is what the market pays today (kr 0.0238); the fair value is what the company's own numbers justify (kr 0.0263). For NanoEcho AB (publ) the two are kr 0.0025 per share apart. That gap is exactly why we show both numbers side by side.
How much is NanoEcho AB (publ) worth?
The market values NanoEcho AB (publ) at about 16.2M SEK (market capitalisation, as of Jul 17, 2026). Per share that is kr 0.0238; our models calculate a fair value of kr 0.0263 per share.
What do the bullish and bearish scenarios say about NANECH?
Our models span a range for NanoEcho AB (publ): cautious scenario kr 0.0263, base kr 0.0263, optimistic kr 0.0295 per share (as of Jul 17, 2026, price kr 0.0238). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of NanoEcho AB (publ) (NANECH)?
Balance-sheet figures for NanoEcho AB (publ) (as of Jul 17, 2026): return on equity −73.9%. They feed the Quality Score of 19/100, which measures business quality independently of the share price.
How far is NANECH from its 52-week high?
NanoEcho AB (publ) trades at kr 0.0238, about 79% below its 52-week high of kr 0.1144 and at the low of kr 0.0238 (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of kr 0.0263 is for.
Which stocks are comparable to NanoEcho AB (publ)?
From the same area (Healthcare) we also value Vertex Pharmaceuticals Incorporated, Regeneron Pharmaceuticals, Inc, argenx SE, Samsung Biologics Co, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is NanoEcho AB (publ) stock attractive at the current price?
The data as of Jul 17, 2026: price kr 0.0238, calculated fair value kr 0.0263 (+11%), Quality Score 19/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of NANECH calculated?
We run NanoEcho AB (publ) through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of kr 0.0263, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.0 % above its aggregate fair value. NanoEcho AB (publ) currently trades 11 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of NanoEcho AB (publ) (NANECH)?
The closing price on Sep 24, 2026 was kr 0.0238. Our model-based fair value is kr 0.0263, about +11% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with NanoEcho AB (publ) right now?
The price is below even our cautious bear case (kr 0.0263). The market is more pessimistic than our downside scenario. The models converge in a tight band (kr 0.0263 to kr 0.0295), unusually little disagreement for a valuation. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Key figures of NanoEcho AB (publ)
How large is the market capitalisation of NanoEcho AB (publ) (NANECH)?
The market capitalisation of NanoEcho AB (publ) is 16.2M SEK (≈ $1.6M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of NanoEcho AB (publ) (NANECH)?
The price-to-sales ratio of NanoEcho AB (publ) is 33.3 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of NanoEcho AB (publ) (NANECH)?
Earnings per share at NanoEcho AB (publ) are kr −0.0500. Earnings per share over the last twelve months: total profit spread across every single share.
What is the return on equity of NanoEcho AB (publ) (NANECH)?
The return on equity (ROE) of NanoEcho AB (publ) is −73.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of NanoEcho AB (publ) (NANECH)?
On an EBIT basis the return on assets of NanoEcho AB (publ) is −78.4% (avg 4y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of NanoEcho AB (publ) (NANECH)?
The operating margin of NanoEcho AB (publ) is −3,199% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at NanoEcho AB (publ) (NANECH)?
Revenue at NanoEcho AB (publ) is growing −82.7% versus a year earlier. How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does NanoEcho AB (publ) (NANECH) generate?
The free cash flow of NanoEcho AB (publ) is −16.6M SEK (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does NanoEcho AB (publ) (NANECH) carry?
The net debt of NanoEcho AB (publ) is 3.3M SEK (fiscal year 2023). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch NanoEcho AB (publ) in the live analysis
One click puts NanoEcho AB (publ) on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
